Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 7:38 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1681–1704 of 13,622 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Dermatologic Disorders Clear all

Conditions: Venous Leg Ulcer
Interventions: Standard Wound Care Alone, Stand Wound Care plus IPC; Other · Device
Lead sponsor: Huntleigh Healthcare Ltd; Industry
Eligibility: Not listed
Enrollment: 136 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 5
States / cities: Hollywood, Florida • North Port, Florida • Tulsa, Oklahoma + 2 more

Conditions: Advanced Solid Tumor, HR+/HER2- Breast Cancer, HR+, HER2-, Advanced Breast Cancer, CCNE1 Amplification, Epithelial Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer, Endometrial Cancer, TNBC - Triple-Negative Breast Cancer
Interventions: AVZO-021, Palbociclib, Fulvestrant, Letrozole, Ribociclib, Abemaciclib, Carboplatin, Sacituzumab Govitecan-hziy; Drug
Lead sponsor: Avenzo Therapeutics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 430 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2030
U.S. locations: 11
States / cities: New Haven, Connecticut • Sarasota, Florida • Tampa, Florida + 8 more

Conditions: Breast Cancer
Interventions: Stereo Navigator Accessory to PEM Flex PET Scanner; Device
Lead sponsor: Naviscan PET Systems; Industry
Eligibility: 25 Years and older · Female only
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008
U.S. locations: 5
States / cities: Boca Raton, Florida • Timonium, Maryland • Portland, Oregon + 2 more

Conditions: Breast Cancer, Ovarian Cancer
Interventions: Not listed
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 19 Years to 100 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2003
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Alopecia Areata
Interventions: Tattoo machine (SOL Nova Device); Device
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older · Male only
Enrollment: 5 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Metastatic Melanoma, Recurrent Cutaneous Melanoma, Stage IV Cutaneous Melanoma AJCC v6 and v7
Interventions: Ibrutinib, Laboratory Biomarker Analysis, Pharmacogenomic Study, Pharmacological Study; Drug · Other
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 13
States / cities: Los Angeles, California • Sacramento, California • Aurora, Colorado + 9 more

Conditions: Breast Cancer
Interventions: Optical Coherence Tomography; Device
Lead sponsor: Diagnostic Photonics, Inc.; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2019
U.S. locations: 1
States / cities: Urbana, Illinois

Conditions: Inflammatory Bowel Diseases
Interventions: Serial Biopsy; Procedure
Lead sponsor: Terrence A Barrett; Other
Eligibility: 18 Years to 90 Years
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Breast Cancer
Interventions: Physician Counseling; Behavioral
Lead sponsor: Baystate Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2006
U.S. locations: 1
States / cities: Springfield, Massachusetts

Conditions: Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Malignant Neoplasm in the Brain, Prognostic Stage IV Breast Cancer AJCC v8
Interventions: Copanlisib, Fulvestrant; Drug
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 7
States / cities: Sacramento, California • Boston, Massachusetts • New York, New York + 4 more

Conditions: Melanosis
Interventions: 1064nm Q-switch Laser, Glycolic Acid Peels; Device · Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Breast Cancer
Interventions: Denosumab; Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Psoriasis
Interventions: Etanercept plus tacrolimus; Drug
Lead sponsor: University of Medicine and Dentistry of New Jersey; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: New Brunswick, New Jersey

Conditions: Diabetic Foot Ulcer, Offloading
Interventions: Offloading boot: PulseFlow; Device
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 18 Years to 80 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Breast Cancer, Soft Tissue Sarcoma
Interventions: Temozolomide; Drug
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2006
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Port Wine Stain
Interventions: Rapamycin Treatment of Port Wine Stain; Drug
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 1
States / cities: Irvine, California

Conditions: Breast Cancer
Interventions: Talazoparib; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older
Enrollment: 84 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Breast Cancer, Vitamin D Deficiency
Interventions: Not listed
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years to 75 Years · Female only
Enrollment: 240 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Breast Cancer, Breast Neoplasms
Interventions: Pembrolizumab, IRX 2; Drug
Lead sponsor: Providence Health & Services; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Dermatomyositis, Idiopathic Inflammatory Myopathies
Interventions: Sodium Thiosulfate; Drug
Lead sponsor: National Institute of Environmental Health Sciences (NIEHS); NIH
Eligibility: 7 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Breast Cancer, Liquid Biopsy, Early Detection
Interventions: Not listed
Lead sponsor: Syantra Inc.; Industry
Eligibility: 30 Years to 75 Years · Female only
Enrollment: 2,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: Phoenix, Arizona • New York, New York

Conditions: Breast Carcinoma
Interventions: Non-Interventional Study; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 324 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 3
States / cities: Scottsdale, Arizona • Tucson, Arizona • Jacksonville, Florida

Conditions: Plantar Fibromatosis, Ledderhose Disease
Interventions: EN3835, Placebo; Biological · Other
Lead sponsor: Endo USA Inc., a Keenova Therapeutics Company; Industry
Eligibility: 18 Years and older
Enrollment: 436 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 63
States / cities: Mesa, Arizona • Scottsdale, Arizona • Tucson, Arizona + 55 more

Conditions: Breast Cancer
Interventions: PET Imaging With Cu-64 Labeled Trastuzumab; Radiation
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2013
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

Intermittent Pneumatic Compression of the Thigh

Study of AVZO-021 in Patients With Advanced Solid Tumors

Pilot Study to Evaluate High Resolution PET Image-Guidance for Sampling of Breast Abnormalities

Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk

Follicular Revival in Treatment-resistant Alopecia Areata: Evaluating Use of Micro-needling

Ibrutinib in Treating Patients With Refractory Metastatic Cutaneous Melanoma

Real Time Optical Coherence Tomography (OCT) of Human Tissue

Regulation of Mucosal Healing in Inflammatory Bowel Disease

Effect of Counseling on Psychological Stress Amongst Women Felt to be at High Risk for Breast Cancer Development

A Study of a New Drug Combination, Copanlisib and Fulvestrant, in Advanced Breast Cancer

A Pilot Study Testing 1064nm Q-switch Laser Versus Glycolic Acid Peels for the Treatment of Melasma

Denosumab for Breast Cancer With Bone Mets

Etanercept With Tacrolimus for Psoriasis

Novel Offloading for Diabetic Foot Ulcers With PulseFlow: A Prospective Study

Continuous Temozolomide in Patients With Advanced or Metastatic Soft Tissue Sarcoma or Metastatic Breast Cancer

A Randomized Trial to Study Combined Pulsed Dye Laser and Rapamycin Treatment of Port Wine Stain Birthmarks.

Real-World Outcomes of US Talazoparib-Treated Patients With Locally Advanced or Metastatic Breast Cancer

Epidemiological Analysis of Vitamin D and Breast Cancer Risk in Saudi Arabian Women

Pembrolizumab, IRX-2, and Chemotherapy in Triple Negative Breast Cancer

Sodium Thiosulfate for Treatment of Calcinosis Associated With Juvenile and Adult Dermatomyositis

Clinical Validation of Early Detection Blood Test for Universal Large-scale Breast Cancer Screening

CARE: Cancer Risk Perception and Women of Color

Study to Assess EN3835 in the Treatment of Plantar Fibromatosis (Also Known as Ledderhose Disease)

PET Imaging With Cu-64 Labeled Trastuzumab in HER2+ Metastatic Breast Cancer